share_log

This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

這位百思買分析師看好市場;以下是週一的五個頂級升級方案
Benzinga ·  06/17 21:51

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

頂尖華爾街分析師改變對這些頂級股票的前景看法。如需全面了解所有分析師評級的變化,包括升級、降級和啓動,請參閱我們的分析師評級頁面。

  • Goldman Sachs analyst Susan Maklari upgraded the rating for Toll Brothers, Inc. (NYSE:TOL) from Sell to Neutral, while raising the price target from $112 to $124. Toll Brothers shares fell 1.2% to close at $119.32 on Friday. See how other analysts view this stock.
  • Piper Sandler analyst Edward Tenthoff upgraded Fate Therapeutics, Inc. (NASDAQ:FATE) from Neutral to Overweight and booted the price target from $4 to $6. Fate Therapeutics shares fell 4% to settle at $3.61 on Friday. See how other analysts view this stock.
  • B of A Securities analyst George Staphos upgraded the rating for Greif, Inc. (NYSE:GEF) from Neutral to Buy, while increasing the price target from $76 to $77. Greif shares fell 0.7% to settle at $60.73 on Friday. See how other analysts view this stock. See how other analysts view this stock.
  • Truist Securities analyst Bill Chappell upgraded Keurig Dr Pepper Inc. (NASDAQ:KDP) from Sell to Hold and boosted the price target from $27 to $34. Keurig Dr Pepper shares fell 0.1% to close at $34.04 on Friday. See how other analysts view this stock.
  • UBS analyst Michael Lasser upgraded the rating for Best Buy Co., Inc. (NYSE:BBY) from Neutral to Buy, while raising the price target from $85 to $106. Best Buy shares fell 0.6% to settle at $87.21 on Friday. See how other analysts view this stock.
  • 高盛的分析師Susan Maklari將Toll Brothers公司(NYSE:TOL)的評級從賣出升級到中立,將價格目標從112美元升至124美元。週五,Toll Brothers的股價下跌1.2%,收盤價爲119.32美元。請查看其他分析師對這支股票的看法。
  • Piper Sandler的分析師Edward Tenthoff將Fate Therapeutics公司(NASDAQ:FATE)的評級從中立升級至超額表現,並將價格目標從4美元提高至6美元。週五,Fate Therapeutics的股價下跌4%,收於3.61美元。請查看其他分析師對這支股票的看法。
  • B of A Securities的分析師George Staphos將Greif公司(NYSE:GEF)的評級從中立升級至買入,並將價格目標從76美元增加至77美元。週五,Greif的股價下跌0.7%,收盤價爲60.73美元。請查看其他分析師對這支股票的看法。
  • Truist Securities的分析師Bill Chappell將Keurig Dr Pepper公司(NASDAQ:KDP)的評級從賣出升級到持有,並將價格目標從27美元提高至34美元。週五,Keurig Dr Pepper的股價下跌0.1%,收盤價爲34.04美元。請查看其他分析師對這支股票的看法。
  • UBS的分析師Michael Lasser將Best Buy公司(NYSE:BBY)的評級從中立升級到買入,並將價格目標從85美元提高至106美元。週五,百思買的股價下跌0.6%,收盤價爲87.21美元。請查看其他分析師對這支股票的看法。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論